Table 2:

Overview of topics prescribing clinicians should discuss with patients when prescribing oral glucocorticoids.

ConsiderationsEligible PatientsTimingComments
Risk for developing exogenous Cushing syndromeAll patients on long-term supraphysiologic glucocorticoid therapyAt the time of initiationThere are many sequelae of exogenous Cushing syndrome. Patients should be educated on the most common and clinically significant, including weight gain, sarcopenia, hyperglycemia, hypertension, bone demineralization.
Risk for developing chronic adrenal insufficiencyEven transient adrenal insufficiency requires education to raise awareness for the need to stress dose when appropriate
Education on stress dosing strategiesPatients on long-term supraphysiologic glucocorticoid therapy who have reduced dosing to physiologic, or subphysiologic, levels.At least at the time when dosing approaches a physiologic range.Dedicated education should be provided to prepare patients with confirmed, or likely, adrenal insufficiency for routine and emergent stress dosing.
Education on injectable emergency glucocorticoid administration
Glucocorticoid withdrawal syndromePatients on long-term supraphysiologic glucocorticoid therapy who are ready to begin tapering the dose.At the time glucocorticoid tapering beginsSome patients on l​​ong term supraphysiologic glucocorticoid therapy experience symptoms as the doses are tapered.
ConsiderationsEligible PatientsTimingComments
Risk for developing exogenous Cushing syndromeAll patients on long-term supraphysiologic glucocorticoid therapyAt the time of initiationThere are many sequelae of exogenous Cushing syndrome. Patients should be educated on the most common and clinically significant, including weight gain, sarcopenia, hyperglycemia, hypertension, bone demineralization.
Risk for developing chronic adrenal insufficiencyEven transient adrenal insufficiency requires education to raise awareness for the need to stress dose when appropriate
Education on stress dosing strategiesPatients on long-term supraphysiologic glucocorticoid therapy who have reduced dosing to physiologic, or subphysiologic, levels.At least at the time when dosing approaches a physiologic range.Dedicated education should be provided to prepare patients with confirmed, or likely, adrenal insufficiency for routine and emergent stress dosing.
Education on injectable emergency glucocorticoid administration
Glucocorticoid withdrawal syndromePatients on long-term supraphysiologic glucocorticoid therapy who are ready to begin tapering the dose.At the time glucocorticoid tapering beginsSome patients on l​​ong term supraphysiologic glucocorticoid therapy experience symptoms as the doses are tapered.
Table 2:

Overview of topics prescribing clinicians should discuss with patients when prescribing oral glucocorticoids.

ConsiderationsEligible PatientsTimingComments
Risk for developing exogenous Cushing syndromeAll patients on long-term supraphysiologic glucocorticoid therapyAt the time of initiationThere are many sequelae of exogenous Cushing syndrome. Patients should be educated on the most common and clinically significant, including weight gain, sarcopenia, hyperglycemia, hypertension, bone demineralization.
Risk for developing chronic adrenal insufficiencyEven transient adrenal insufficiency requires education to raise awareness for the need to stress dose when appropriate
Education on stress dosing strategiesPatients on long-term supraphysiologic glucocorticoid therapy who have reduced dosing to physiologic, or subphysiologic, levels.At least at the time when dosing approaches a physiologic range.Dedicated education should be provided to prepare patients with confirmed, or likely, adrenal insufficiency for routine and emergent stress dosing.
Education on injectable emergency glucocorticoid administration
Glucocorticoid withdrawal syndromePatients on long-term supraphysiologic glucocorticoid therapy who are ready to begin tapering the dose.At the time glucocorticoid tapering beginsSome patients on l​​ong term supraphysiologic glucocorticoid therapy experience symptoms as the doses are tapered.
ConsiderationsEligible PatientsTimingComments
Risk for developing exogenous Cushing syndromeAll patients on long-term supraphysiologic glucocorticoid therapyAt the time of initiationThere are many sequelae of exogenous Cushing syndrome. Patients should be educated on the most common and clinically significant, including weight gain, sarcopenia, hyperglycemia, hypertension, bone demineralization.
Risk for developing chronic adrenal insufficiencyEven transient adrenal insufficiency requires education to raise awareness for the need to stress dose when appropriate
Education on stress dosing strategiesPatients on long-term supraphysiologic glucocorticoid therapy who have reduced dosing to physiologic, or subphysiologic, levels.At least at the time when dosing approaches a physiologic range.Dedicated education should be provided to prepare patients with confirmed, or likely, adrenal insufficiency for routine and emergent stress dosing.
Education on injectable emergency glucocorticoid administration
Glucocorticoid withdrawal syndromePatients on long-term supraphysiologic glucocorticoid therapy who are ready to begin tapering the dose.At the time glucocorticoid tapering beginsSome patients on l​​ong term supraphysiologic glucocorticoid therapy experience symptoms as the doses are tapered.
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close